AMLXAmylyx Pharmaceuticals, Inc.Aug 6, 2026Q2 2026
Read transcript →Amylyx Pharmaceuticals, Inc. (AMLX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$27.92
-1.29%
Mkt Cap $3.41B
AMLXAmylyx Pharmaceuticals, Inc.Aug 6, 2026AMLXAmylyx Pharmaceuticals, Inc.May 7, 2026Q1 2026
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Mar 3, 2026Q4 2025
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Nov 6, 2025Q3 2025
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Aug 7, 2025Q2 2025
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.May 10, 2025Q1 2025
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Mar 4, 2025Q4 2024
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Nov 9, 2024Q3 2024
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Aug 9, 2024Q2 2024
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.May 9, 2024Q1 2024
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Feb 22, 2024Q4 2023
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Nov 11, 2023Q3 2023
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Aug 10, 2023Q2 2023
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.May 11, 2023Q1 2023
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Mar 13, 2023Q4 2022
Read transcript →AMLXAmylyx Pharmaceuticals, Inc.Nov 13, 2022Q3 2022
Read transcript →